BioAge Labs (BIOA) Enterprise Value (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Enterprise Value data on file, last reported at -$383.2 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 3.75% year-over-year to -$383.2 million; the trailing twelve-month figure through Mar 2026 stood at -$383.2 million (up 3.75% YoY), and the FY2025 full-year result was -$281.1 million, up 20.61% from the prior year.
• Enterprise Value fell to -$383.2 million in Q1 2026, from -$281.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$25.0 million in Q4 2023 to a low of -$398.1 million in Q1 2025.
• A 4-year average of -$281.4 million and a median of -$297.0 million in 2025 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value plunged 1318.68% in 2024 and rose 20.61% in 2025, its largest moves.
• Tracing BIOA's Enterprise Value over 4 years: stood at -$25.0 million in 2023, then sank by 1318.68% to -$354.1 million in 2024, then climbed by 20.61% to -$281.1 million in 2025, then tumbled by 36.32% to -$383.2 million in 2026.
• Business Quant data shows BIOA's Enterprise Value at -$383.2 million in Q1 2026, -$281.1 million in Q4 2025, and -$285.5 million in Q3 2025.